Skip to main content

Animations

MJFF Publications

6526 - 6550 of 9148 Results
Title
Year
  • Year
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2020
  • Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease
    2021
    Summary Details
    RESTRICTED
    Title: Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108465
    Citation Count: 19
  • Special Issue on new therapeutic approaches to Parkinson disease
    2022
    Summary Details
    RESTRICTED
    Title: Special Issue on new therapeutic approaches to Parkinson disease
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213
    Citation Count: 11
  • Preserved motor memory in Parkinson's disease
    2022
    Summary Details
    RESTRICTED
    Title: Preserved motor memory in Parkinson's disease
    Journal Name: Neuropsychologia
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108161
    Citation Count: 15
  • Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain Stimulation
    2022
    Summary Details
    OPEN
    Title: Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain Stimulation
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.015
    Citation Count: 5
  • ID:16220 Visualization Tool for DBS Programming Used With a Multiple-Source, Constant-Current System Reduces Initial Programming Time
    2022
    Summary Details
    RESTRICTED
    Title: ID:16220 Visualization Tool for DBS Programming Used With a Multiple-Source, Constant-Current System Reduces Initial Programming Time
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.02.012
    Citation Count: 0
  • ID:16203 Brachial Plexus Stimulation for Refractory Neuropathic Upper Limb Pain in a Traumatic Brain Injury Patient
    2022
    Summary Details
    RESTRICTED
    Title: ID:16203 Brachial Plexus Stimulation for Refractory Neuropathic Upper Limb Pain in a Traumatic Brain Injury Patient
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.02.011
    Citation Count: 0
  • Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension
    2022
    Summary Details
    RESTRICTED
    Title: Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.002
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazine
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.017
    Citation Count: 8
  • Smoking is associated with age at disease onset in Parkinson's disease
    2022
    Summary Details
    RESTRICTED
    Title: Smoking is associated with age at disease onset in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.03.005
    Citation Count: 6
  • Subacute tremor and ataxia: Diligence in pursuit of a diagnosis
    2022
    Summary Details
    RESTRICTED
    Title: Subacute tremor and ataxia: Diligence in pursuit of a diagnosis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.016
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013
    Citation Count: 23
  • Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's disease
    2022
    Summary Details
    RESTRICTED
    Title: Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.010
    Citation Count: 21
  • L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome
    2022
    Summary Details
    RESTRICTED
    Title: L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.023
    Citation Count: 8
  • Pallidal neuronal activity in multiple system atrophy type P and Parkinson's disease
    2022
    Summary Details
    RESTRICTED
    Title: Pallidal neuronal activity in multiple system atrophy type P and Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.007
    Citation Count: 1
  • White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's disease
    2021
    Summary Details
    RESTRICTED
    Title: White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.031
    Citation Count: 20
  • Author response to comment on “The association between pain and impulse control behaviours in Parkinson's disease”
    2021
    Summary Details
    RESTRICTED
    Title: Author response to comment on “The association between pain and impulse control behaviours in Parkinson's disease”
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.011
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scores
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Consistent skin α-synuclein positivity in REM sleep behavior disorder – A two center two-to-four-year follow-up study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.007
    Citation Count: 37
  • Plasma NfL, clinical subtypes and motor progression in Parkinson's disease
    2021
    Summary Details
    OPEN
    Title: Plasma NfL, clinical subtypes and motor progression in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.016
    Citation Count: 60
  • Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach
    2021
    Summary Details
    RESTRICTED
    Title: Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.05.011
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Trajectories of pain over 6 years in early Parkinson’s disease: ICICLE-PD
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-021-10586-7
    Citation Count: 12
  • Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson’s disease
    2020
    Summary Details
    RESTRICTED
    Title: Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson’s disease
    Journal Name: Artificial Intelligence in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.artmed.2020.101807
    Citation Count: 33
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.